Skip to content

JPLT2 protocol (CITA and ITEC regimen)for the pediatric liver tumor in Japan

JPLT2 protocol (CITA and ITEC regimen)for the pediatric liver tumor in Japan - JPLT(Japanese Study Group for Pediatric Liver Tumor)-2 protocol

Status
Active, not recruiting
Phases
Phase 2
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000001116
Enrollment
220
Registered
2008-04-09
Start date
2000-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatoblastoma hepatocellular carcinoma

Interventions

None listed

Sponsors

Japanese Study Group for Pediatric Liver Tumors
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. A child between 6 months and 5 years of age has liver tumors detected by imaging and shows an abnormally high level of serum AFP.(Note, however, that it is necessary to exclude the metastatic liver tumor by totally diagnostic imaging. In addition, when chemotherapy will be performed ahead, pathological diagnosis by biposy is preferable to be done for accurate diagnosis.) 2. A child under 6 months or more 5 years of age had intrahepatic tumor which was diagnosed by pathology. 3 In cases with liver tumor whose serum AFP is normal level, pathological diagnosis by biopsy is obtained regardless of age.

Exclusion criteria

Exclusion criteria: Note that, even if an intrahepatic tumor, the benign liver tumor, hepatocellular carcinoma, and metastatic liver tumors should be excluded.

Design outcomes

Primary

MeasureTime frame
Effect of tumor reduction Improvement of event-free and overall survivals Safety

Secondary

MeasureTime frame
Pancytopenia Digestive organ dysfunction Late complications (cardiac dysfunction, growth disorder, hearing disorder)

Countries

Japan

Contacts

Public ContactSho Kurihara

Hiroshima university hospital Pediatric Surgery

kogura@hiroshima-u.ac.jp082-257-5216

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026